NCT01605305
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
Not specified
Clinical trial condition
Esophageal Neoplasms
Explore clinical trials studying Esophageal Neoplasms. Study availability and eligibility vary by location and protocol.
304 public trials
107 recruiting studies
Esophageal Neoplasms trial results
Active, Not Recruiting
Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors
NCT06781983
- Conditions
- Adnexal Diseases, Advanced or Metastatic Solid Tumors, Breast Diseases, +64 more
- Locations
-
- Massachusetts General Hospital - Boston Boston, Massachusetts, United States
- John Theurer Cancer Center Hackensack, New Jersey, United States
- Mount Sinai Tisch Cancer Center New York, United States
- NEXT Oncology - Dallas Dallas, Texas, United States
Active, Not Recruiting
A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy
NCT04543617
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Florida Cancer Specialists - Fort Myers (Broadway) Fort Myers, Florida, United States
- Cancer Center of Kansas Wichita, Kansas, United States
- Great Lakes Cancer Center Williamsville, New York, United States
- Instituto de Investigaciones Metabolicas (Idim) Buenos Aires, Argentina
Active, Not Recruiting
A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus01)
NCT06304974
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
Active, Not Recruiting
Phase II Study of Induction Chemoimmunotherapy Followed by Radiotherapy and Organ Preservation in Resectable ESCC
NCT07711470
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
- Locations
-
- National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences Beijing, China
Active, Not Recruiting
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
NCT05078047
- Conditions
- Adenocarcinoma, Basal Cell Carcinoma, Breast Diseases, +69 more
- Locations
-
- Institut de cancérologie de l'Ouest Angers, France
- Clinique Sainte Catherine Avignon, France
- Centre Hospitalier de la Côte Basque Bayonne, France
- CHU Bordeaux - Hôpial Saint André Bordeaux, France
Active, Not Recruiting
Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy
NCT03712566
- Conditions
- Anal Canal Squamous Cell Carcinoma, Cancer, Carcinoma, +22 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
Active, Not Recruiting
Predictive Biomarkers for PD-1 Inhibitor Response in Squamous Cell Carcinoma
NCT07147361
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Cervical Squamous Cell Carcinoma, +16 more
- Locations
-
- Department of Etiology and Carcinogenesis Beijing, Beijing Municipality, China
Active, Not Recruiting
Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
NCT06165380
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
- Locations
-
- Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
Active, Not Recruiting
Low-Dose Radiotherapy With Retlirafusp Alfa and Chemotherapy as Neoadjuvant Therapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
NCT07682376
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
- Locations
-
- Harbin Medical University Cancer Hospital, No. 150 Haping Road, Nangang District, Harbin, Heilongjiang Province, China Harbin, Heilongjiang, China